Effect of Selenium versus N-acetyl cysteine on Oxidative Stress and Clinical Outcome of Idiopathic Pulmonary Fibrosis patients: a randomized controlle - Trial PACTR201610001800151
Access comprehensive clinical trial information for PACTR201610001800151 through Pure Global AI's free database. This Not Applicable trial is sponsored by self funding and is currently Completed. The study focuses on Respiratory; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
self funding
Timeline & Enrollment
Not Applicable
Apr 03, 2012
Apr 08, 2014
Summary
Idiopathic pulmonary fibrosis (IPF) is a rare and fatal disease with a 3-5 years survival. It remains incompletely understood despite intense research and the arrival of new drugs with unproven efficacy in limiting mortality and are associated with severe side effects. Novel therapeutic targets are still required in IPF. This study aimed to evaluate the impact of selenium as a potent antioxidant, on the oxidative stress and clinical outcome of IPF patients and to assess selenium efficacy and tolerability in this patient population.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201610001800151
Non-Device Trial